Chiu Yen-Chun, Yang Shih-Chieh, Chen Hung-Shu, Kao Yu-Hsien, Tu Yuan-Kun, Chung Kao-Chi
Department of Orthopaedic Surgery and Anesthesiology, E-Da Hospital, I-Shou University, Taiwan, ROC.
J Spinal Disord Tech. 2012 Dec;25(8):E245-53. doi: 10.1097/BSD.0b013e31825ef90f.
Percutaneous vertebroplasty (PV) with polymethylmethacrylate is widely used to treat osteoporotic vertebral compression fracture and satisfactory clinical outcomes have been reported in the literature. However, recurrent or persistent back pain after PV is not uncommon. Sometimes, the pain may result from pathogenesis within the previously treated vertebra. In this study, we evaluated the efficacy and safety of repeat PV for treating patients with recurrent back pain caused by the previously cemented vertebrae.
We retrospectively reviewed the medical records of 18 patients who underwent repeat PV to treat symptomatic cemented vertebrae. Patients were categorized into 3 groups based on clinical presentation and imaging studies: those with refracture (RF), residual vacuum (RV), and osteonecrosis (ON) along the bone-cement interface. A bipedicle approach was used for repeat PV in all patients. The visual analogue scale (VAS) and modified Brodsky criteria were used to evaluate clinical outcomes before and after surgery. The Kruskal-Wallis test, Wilcoxon signed-rank test, and Spearman correlation analyses were used to analyze patient surgical prognosis and radiologic findings.
Nine patients were diagnosed with RF, 5 with RV, and 4 with ON. The average VAS score was 77.1 (range, 62-90) before repeat PV (80.1, 72.4, and 76.3 for the RF, RV, and ON groups, respectively) and 34.4 (range, 25-45) after repeat PV treatment (33.1, 36.8, and 34.3 for the RF, RV, and ON groups, respectively). The VAS score significantly decreased in all 3 groups. The vertebral body height was significantly restored by a mean of 13.9% across all groups (17.8%, 12.7%, and 6.8% in the RF, RV, and ON groups, respectively). Fifteen patients recovered from vertebral compression fracture and regained their preinjury activities of daily living. No surgery-related complications occurred except asymptomatic cement leakage in 5 patients.
The results of this research demonstrate that repeat PV may be an effective method for relieving recurrent or persistent pain in patients with symptomatic cemented vertebrae, allowing them to regain functional activity.
经皮聚甲基丙烯酸甲酯椎体成形术(PV)被广泛用于治疗骨质疏松性椎体压缩骨折,文献报道其临床疗效令人满意。然而,PV术后复发性或持续性背痛并不少见。有时,疼痛可能源于先前治疗椎体内部的发病机制。在本研究中,我们评估了重复PV治疗先前椎体注入骨水泥后出现复发性背痛患者的疗效和安全性。
我们回顾性分析了18例行重复PV治疗有症状的注入骨水泥椎体患者的病历。根据临床表现和影像学检查将患者分为3组:骨水泥界面处出现再骨折(RF)、残留真空(RV)和骨坏死(ON)的患者。所有患者重复PV均采用双侧椎弓根入路。采用视觉模拟评分法(VAS)和改良的布罗茨基标准评估手术前后的临床疗效。采用Kruskal-Wallis检验、Wilcoxon符号秩检验和Spearman相关性分析来分析患者的手术预后和影像学表现。
9例患者诊断为RF,5例为RV,4例为ON。重复PV术前平均VAS评分为77.1(范围62 - 90)(RF组、RV组和ON组分别为80.1、72.4和76.3),重复PV治疗后为34.4(范围25 - 45)(RF组、RV组和ON组分别为33.1、36.8和34.3)。所有3组的VAS评分均显著降低。所有组椎体高度平均显著恢复13.9%(RF组、RV组和ON组分别为17.8%、12.7%和6.8%)。15例患者从椎体压缩骨折中康复,恢复了伤前的日常生活活动能力。除5例患者出现无症状骨水泥渗漏外,未发生与手术相关的并发症。
本研究结果表明,重复PV可能是缓解有症状的注入骨水泥椎体患者复发性或持续性疼痛、使其恢复功能活动的有效方法。